Verification evidence is still being completed.
PDF / print export
ARTIDIS AG
Basel, Switzerland
- Verified lead
- Marija Plodinec
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer and Co-Founder
- 2026 technical specialization
- Nanomechanical Cancer Diagnostics, Atomic Force Microscopy, and Clinical Decision Support
- Review cycle
- 24 April 2026
- Full address
- Hochbergerstrasse 60C, 4057 Basel, Switzerland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- The Org organization chart naming Marija Plodinec as CEO and Co-Founder of ARTIDIS AG.
- Editorial note
- Basel Biozentrum spin-off with named co-founder CEO, ARTIDIS nanomechanical cancer diagnostics platform, and completed clinical-trial milestones.
Nanomechanical Cancer Diagnostics, Atomic Force Microscopy, and Clinical Decision Support
Biozentrum University of Basel spin-off, Public co-founder CEO disclosure, Clinical-trial completion record
Basel Biozentrum spin-off with named co-founder CEO, ARTIDIS nanomechanical cancer diagnostics platform, and completed clinical-trial milestones.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Basel, Switzerland
ARTIDIS AG
Nanomechanical Cancer Diagnostics, Atomic Force Microscopy, and Clinical Decision Support · Diagnostic platform commercialization
Basel Biozentrum spin-off with named co-founder CEO, ARTIDIS nanomechanical cancer diagnostics platform, and completed clinical-trial milestones.
- Lead
- Marija Plodinec (verified ↗)
- Address
- Hochbergerstrasse 60C, 4057 Basel, Switzerland (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- Diagnostic platform commercialization
- Capabilities
- Nanomechanical Tissue Analysis · Atomic Force Microscopy Platform · ARTIDISNet Clinical Decision Support
- Founded
- 2014
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Marija Plodinec
Chief Executive Officer and Co-Founder
Full addressHochbergerstrasse 60C, 4057 Basel, Switzerland
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Switzerland Global Enterprise (S-GE) exhibitor listing for ARTIDIS AG at Hochbergerstrasse 60C, Basel.
Open sourceDiagnostic platform commercialization
Basel, Switzerland. Nanomechanical Cancer Diagnostics, Atomic Force Microscopy, and Clinical Decision Support. Review completed on 24 Apr 2026.
Swissmedic and EU MDR / IVDR for diagnostic oversight
Biozentrum University of Basel spin-off, Public co-founder CEO disclosure, Clinical-trial completion record
Nanomechanical Cancer Diagnostics, Atomic Force Microscopy, and Clinical Decision Support
Basel Biozentrum spin-off with named co-founder CEO, ARTIDIS nanomechanical cancer diagnostics platform, and completed clinical-trial milestones.
Editorial note
ARTIDIS is a Biozentrum (University of Basel) spin-off applying nanomechanical tissue properties to cancer diagnostics, with a named co-founder CEO and completed clinical-trial milestones.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Nanomechanical Tissue Analysis
Atomic Force Microscopy Platform
ARTIDISNet Clinical Decision Support
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
ARTIDIS nanomechanical platform
Atomic force microscopy workflow
Clinical validation partnerships
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is ARTIDIS AG located?
- ARTIDIS AG operates from Hochbergerstrasse 60C, 4057 Basel, Switzerland, Basel, Switzerland.
- Who runs ARTIDIS AG?
- ARTIDIS AG is led by Marija Plodinec, Chief Executive Officer and Co-Founder. Verified 24 Apr 2026.
- What does ARTIDIS AG do?
- Basel Biozentrum spin-off with named co-founder CEO, ARTIDIS nanomechanical cancer diagnostics platform, and completed clinical-trial milestones. Core capabilities: Nanomechanical Tissue Analysis, Atomic Force Microscopy Platform, ARTIDISNet Clinical Decision Support.
Editorial context
Related technical briefs
Briefs that name Basel as a covered market or city.